Featured Research

Lowering Dosage of Retinopathy Injection Treatment Did Not Decrease Effectiveness Intravitreous bevacizumab has become an increasingly common way to treat retinopathy of prematurity (ROP) in infants, but systemic toxicity remains one of its potentially dangerous side effects.

Read Featured Research

Division Summary

Research and Training Details

Joint Appointment Faculty1
Research Fellows and Post Docs9
Research Graduate Students2
Total Annual Grant Award Dollars$1,038,537

Clinical Activities and Training

Staff Physicians1
Clinical Fellows1
Inpatient Encounters2,040
Outpatient Encounters32,294